ESG News For Genzyme Corporation

These sites contributed news to this page:

Jeffrey Modell Foundation and X4 Pharmaceuticals to Sponsor First Genetic Screening Study for Patients with WHIM Syndrome

Study aims to establish a genetic screening approach to aid in diagnosis of patients with WHIM syndrome

We use cookies to improve the usability of our site and to analyze traffic patterns so we can improve our utility. Please agree to our use of cookies.

Decline

ESG News For Genzyme Corporation

Jeffrey Modell Foundation and X4 Pharmaceuticals to Sponsor First Genetic Screening Study for Patients with WHIM Syndrome